Explore more publications!

Martinique Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Martinique Science Reporter.

Press releases published on October 20, 2025

Adaptyx Raises $14M in Seed Financing to Launch Wearable Platform for Continuous Multi-Analyte Molecular Monitoring
zSpace Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Market and Regains Compliance with Nasdaq Listing Requirements
Commerce Introduces BigCommerce Payments Powered by PayPal
MBX Biosciences to Participate in November Investor Conferences
Arnatar Therapeutics Announces Upcoming Presentations at AASLD The Liver Meeting® 2025 and ASN Kidney Week 2025
CareCloud to Present at the 2025 ThinkEquity Conference
GSI Technology to Announce Fiscal Second Quarter 2026 Results on October 30, 2025
Valitor Presents Preclinical Data Demonstrating VLTR-559 Achieves Superior Durability and Sustained Anti-VEGF Activity with a Favorable Safety Profile as a Treatment for Wet AMD
CervoMed to Present at the Emerging Growth Conference
BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025
Connect Expands Access to Funding Through Curated Venture List
Certara Scientists are Among the Topmost Cited Biopharma Researchers
Judo Bio Presents Data Demonstrating Sustained, Kidney-Selective Gene Silencing Across Species
IDI Announces Integration with TazWorks to Expand Access to IDI’s Best-in-Class Identity Intelligence in the Background Screening Industry
Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
Two Posters at ESMO Congress 2025 Highlight Immutep’s Focus on Changing Treatment Landscape in First Line Non-Small Cell Lung Cancer
Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion
Oncotelic to Present at the LD Micro Main Event XIX
RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Announce Positive Topline Data from Phase 2 Trial of RPT904 (JYB1904) in Chronic Spontaneous Urticaria
Aeries Technology Expands Private Equity Partnerships with New Client Engagement in Mexico

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions